Five anonymised historical charts were dealt to every player. The Monkey Index returned -0.26% across the same tape.
105 desks completed all five charts.
Wall Street was hanging on every trial headline as drugmakers jostled through the autumn 2020 vaccine race. Over the next five trading days the stock found its footing, bouncing +2.6% to stem the drift.
Double-dip recession scares were rattling global markets in the summer of 2010, knocking down reliable life-sciences suppliers alongside the broader market. That weakness found its floor right here, with the stock picking up +1.7% over the next five trading days.
Russia's invasion of Ukraine had upended global energy markets, leaving refiners right at the centre of a furious commodity rally. The buying momentum carried straight through, adding a further 7.2% over the next five days.
China's booming economy had kicked off a massive commodities supercycle, placing oilfield service providers right at the centre of a global energy rush. The stock consolidated that momentum with a modest 1.0% gain over the hidden week.
Global factory demand was powering the mid-2000s industrial boom, pushing heavy automation stalwarts to fresh heights by late autumn. The momentum broke immediately over the next five sessions, handing back 4.3%.